Momoko Nishikori

26PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesOncology and carcinogenesis not elsewhere classifiedHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 24, 2026
Real-World Safety and Efficacy of Pola-R-CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients.

|Jul 06, 2026
Prolonged isolated dysgeusia as an initial manifestation of neurolymphomatosis in primary central nervous system lymphoma: illustrative case.

|May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: phase 2 of NCCH1903/ATTACK trial.

|Aug 11, 2025
Prolonged chimeric antigen receptor-T apheresis to infusion time is associated with inferior outcomes in diffuse large B-cell lymphoma.

Suguru Morimoto, Tomoyasu Jo, Toshio Kitawaki

|Jul 09, 2025
Consistent ex vivo cell proliferation during manufacturing predicts favourable outcomes post-CAR-T-cell therapy.

Tomoyasu Jo, Yasuyuki Arai, Tomoshige Shimizu

|Apr 23, 2025
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 6. Burkitt lymphoma/high-grade B-cell lymphoma (BL/HGBL).

Momoko Nishikori, Eisei Kondo

Pageof 5

Frequent Collaborators

6 joint publications

Tomoyasu Jo

6 joint publications

Yasuyuki Arai

6 joint publications

Junya Kanda

6 joint publications

Akifumi Takaori-Kondo